BioLine RX Ltd (NASDAQ:BLRX)
| 1.93 Data as of 4:00pm ET |  +0.10 / +5.46%Today’s Change | 1.20 Today|||52-Week Range 3.09 | +19.14% Year-to-Date |
Latest BLRX News | Press Releases
| ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog Jan 21 / Zacks.com | Zacks Rank #1 Additions for Monday - Tale of the Tape Jan 19 / Zacks.com |
Today’s Trading
| Previous close | 1.83 |
| Today’s open | 1.79 |
| Day’s range | 1.79 - 1.93 |
| Volume | 160,824 |
| Average volume (3 months) | 248,702 |
| Market cap | $71.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 01/26/2015
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GLMDGalmed Pharmaceutica... | +0.38 | +5.93% |
| VCELVericel Corp | +0.10 | +3.23% |
| ARQLArQule Inc | +0.04 | +3.64% |
| MSTXMast Therapeutics In... | 0.00 | 0.00% |
Data as of 4:01pm ET, 01/26/2015
Financials
| Next reporting date | March 10, 2015 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
Forecasts
.